Analysis of METTL14 expression in pancreatic cancer and adjacent tissues and its prognostic value for patient outcomes
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.METTL14 expression is elevated in pancreatic cancer (PC) tissues and linked to poorer patient survival. This finding highlights METTL14 as a potential prognostic biomarker for PC, aiding in predicting patient outcomes.
Area Of Science
- Oncology
- Molecular Biology
- Biomarker Discovery
Background
- Pancreatic cancer (PC) remains a significant health challenge with limited prognostic markers.
- Understanding the molecular underpinnings of PC progression is crucial for improving patient outcomes.
Purpose Of The Study
- To investigate the differential expression of METTL14 in pancreatic cancer tissues compared to adjacent normal tissues.
- To analyze the correlation between METTL14 expression levels and clinical outcomes in PC patients.
Main Methods
- Quantitative reverse transcription PCR (RT-qPCR) for mRNA expression analysis.
- Immunohistochemistry for protein expression assessment.
- Kaplan-Meier survival analysis and multivariate COX regression for prognostic evaluation.
Main Results
- METTL14 mRNA and protein expression were significantly higher in PC tissues.
- Positive METTL14 protein expression correlated with advanced tumor AJCC stage, poor differentiation, and lymph node metastasis.
- Patients with METTL14-positive tumors exhibited significantly lower three-year survival rates compared to those with METTL14-negative tumors.
Conclusions
- Elevated METTL14 expression is associated with aggressive clinicopathological features in pancreatic cancer.
- METTL14 serves as a potential independent prognostic biomarker for predicting survival in PC patients.
- Further research into METTL14's role could lead to novel therapeutic strategies for pancreatic cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.